Seattle startup PreemptiveAI received $6.4 million in financing and is committed to using AI technology to improve health care. The company focuses on developing AI software that uses smartphone and wearable device data to predict health outcomes, and is working with Duke University to identify health risks through remote monitoring of patient data. Its potential customers include medical service providers, drug developers and insurance companies, marking an important step in the application of artificial intelligence in the medical field and foreshadowing the possibility of personalized medicine in the future.
Seattle startup PreemptiveAI received $6.4 million in funding to build smart medical models. Utilizing data from smartphones and wearable devices, it develops AI software to predict health outcomes and collaborates with Duke University to remotely monitor patient data to identify health risks. Potential customers include medical service providers, drug developers and insurance companies.
PreemptiveAI’s successful financing and partnership with Duke University demonstrate its great potential in using AI technology to improve healthcare. In the future, we are expected to see the emergence of more AI-based medical solutions, bringing more accurate and efficient medical services to patients.